Intellia Therapeutics Inc. revenue breakdown overview

Intellia Therapeutics Inc. revenue for the last year amounted to 32.87 M EUR, the most of which — 32.87 M EUR — came from its highest performing source at the moment, Genome Editing-based Therapies, the year earlier bringing 48.70 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought Intellia Therapeutics Inc. 32.87 M EUR, and the year before that — 48.70 M EUR.